Development of more selective inhibitor/activators of HDAC isoforms may provide a novel therapeutic approach that can potentially elucidate HDAC isoform specific functions and thereby facilitate enhanced brain recovery after stroke. The gene discussed is HDAC9; the disease is Stroke.